Plain-English translation of NCT05645055 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers want to understand how well biologic medications work for patients whose Crohn's disease causes narrowing (strictures) in the intestines. This is a prospective study, meaning researchers will follow patients forward in time and carefully track what happens. Most previous research on this topic looked backward at past patient records, so this new study will provide fresher, more direct evidence about whether the medication helps.
Recent research suggests that biologic medications may help treat stricturing Crohn's disease, but most evidence comes from looking back at old medical records. This study exists to gather real-time information as patients receive this treatment, so doctors can better understand whether it actually works for this particular type of Crohn's disease.
You likely qualify if…
You likely don't qualify if…
You will receive biologic medication for your stricturing Crohn's disease as part of this study. Researchers will monitor you over time and collect information about how well the medication is working, what side effects you experience, and whether your symptoms improve. This is an observational study, meaning doctors are watching and recording how you respond to the treatment rather than randomly assigning you to different groups.
AI-generated summary from trial data · Jun 14, 2026 · Not medical advice
China
Sponsor
Jinling Hospital, China
Enrollment target
~200 participants
Started
January 2021
Primary completion
January 2024
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
16 Years – 65 Years
Last updated on clinicaltrials.gov in May 2023.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Weiming wm Zhu, Ph.D.
Jinling Hospital, China
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.